Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD to review Veterinary Medicines Regulations
The VMD is assessing the efficiency of the legislation.
It has called for evidence on the Medicines and Medical Devices Act 2021.

The Veterinary Medicines Directorate (VMD) has called for veterinary stakeholders to share evidence on the Medicines and Medical Devices Act 2021.

It comes as the agency examines the structure of the Veterinary Medicines Regulations 2013, assessing its efficiency in protecting animal and public health and the wider environment.

The VMR legislate the UK's veterinary medicines and medicated feeds, including their manufacture, advertising, supply, possession and administration. Under the Windsor Framework, there is separate legislation in Great Britain and in Northern Ireland.

The review hopes to evaluate how well it is meeting these goals, while also avoiding regulatory burden where possible. The VMD will consider where restructuring or consolidation will improve the clarity of VMR legislation and whether it can be better implemented.

The regulations originated from EU legislation, before it was transposed into UK law.

Under the Medicines and Medical Devices Act 2021, the UK has primary powers to amend the legislation where necessary. The UK also has a statutory obligation to assess the legislation and its impact at least once every five years.

The VMR were last amended by the Veterinary Medicines (Amendment, etc.) Regulations 2024.

To help inform the investigation, the VMD has asked that stakeholders share their views and experiences of the VMR. Where possible, the responses should include specific examples.

Although anyone can respond to the inquiry, the VMD has particularly welcomed responses from those involved with veterinary medicines, as well as veterinary surgeons, veterinary nurses and other suitably qualified persons. Farmers, professional animal keepers and pet owners are also invited to share evidence.

Responses can be submitted through the VMD's Citizen Space platform, or sent by email to vmr@vmd.gov.uk using the relevant call for evidence documents.

The call for evidence will close at 23:59 on 26 September 2025.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.